A proper syringe injection technique keeps everything in the right layer
In June 2026 the MHRA approved oral semaglutide, marketed as the Wegovy pill , the first oral GLP-1 receptor agonist licensed in the UK for weight management (distinct from Rybelsus, a lower-dose oral semaglutide licensed for type 2 diabetes)
Bhatia sees microdosing as an option for clients who come to her office with the goal of losing 20 pounds or less or patients who have proved to be sensitive to the side effects of GLP-1, which include nausea, constipation, lack of energy and diarrhea
If youre already familiar with our nutrition approach, well guide you in staying consistent and making progress
The eating patterns, activity levels, and stress and sleep habits you build while taking Mounjaro all contribute